Subramaniam Narayana R, Srinivasalu Vijay Kumar, Balasubramanian Deepak, Pushpaja K U, Nair Anoop Remesan, Prameela Chelakkot, Thankappan Krishnakumar, Iyer Subramania
Department of Head and Neck Oncology, Amrita Institute of Medical Sciences, Amrita University, Kochi, Kerala, India.
Department of Medical Oncology, Amrita Institute of Medical Sciences, Amrita University, Kochi, Kerala, India.
Indian J Cancer. 2017 Jul-Sep;54(3):493-497. doi: 10.4103/ijc.IJC_321_17.
It is estimated that around 10% of all head and neck cancer patients in India are aged over 70 years. Elderly patients are often subjected to palliative or inadequate treatment for head and neck cancers in spite of being candidates for curative intent therapy. In this study we evaluated our use of radical radiotherapy in carcinoma larynx for patients over seventy years of age to determine morbidity, likelihood of completing therapy, functional and oncological outcomes.
132 patients of squamous cell carcinoma of the larynx treated between 2005-2015 at Amrita Institute of Medical Sciences, Kochi who were seventy years of age or older were included. The endpoint for analysis was overall survival. Survival curves were generated using Kaplan Meier method and univariable analysis was performed using log rank test.
The median age of patients was 77 years (range 70-102). All patients (100%) completed radiotherapy with 6 (5%) requiring treatment breaks. All patients had at least minor (grade I/II) toxicities. Grade III toxicities were seen in 10 (8%) of patients. No grade IV reactions or treatment related deaths occurred. When a univariate analysis was performed for determinants of major toxicities with age range, performance status, smoking, number of co-morbidities or TNM stage, no determinants were statistically significant. 2-year disease free survival for stage I, II, III and IV was 100%, 98%, 80% and 64% respectively, and the 2-year overall survival for all four stages was 100%.
Patients over seventy years tolerate radical radiotherapy for treatment of laryngeal cancer. In spite of minor toxicities, all patients completed treatment and had good oncological outcomes. Patients with stage III/IV unfit for concomitant chemotherapy administration treated with radiotherapy alone had a good disease free survival. Curative intent therapy should not be withheld from elderly patients on the basis of age.
据估计,印度所有头颈癌患者中约10%的年龄超过70岁。尽管老年患者适合进行根治性治疗,但他们常常接受姑息性或不充分的头颈癌治疗。在本研究中,我们评估了70岁以上喉癌患者接受根治性放疗的情况,以确定其发病率、完成治疗的可能性、功能和肿瘤学结局。
纳入2005年至2015年期间在高知市阿姆里塔医学科学研究所接受治疗的132例70岁及以上的喉鳞状细胞癌患者。分析的终点是总生存期。使用Kaplan-Meier方法生成生存曲线,并使用对数秩检验进行单变量分析。
患者的中位年龄为77岁(范围70-102岁)。所有患者(100%)完成了放疗,其中6例(5%)需要中断治疗。所有患者均至少出现轻度(I/II级)毒性反应。10例(8%)患者出现III级毒性反应。未发生IV级反应或与治疗相关的死亡。对年龄范围、体能状态、吸烟、合并症数量或TNM分期等主要毒性反应的决定因素进行单变量分析时,没有任何决定因素具有统计学意义。I期、II期、III期和IV期的2年无病生存率分别为100%、98%、80%和64%,所有四个阶段的2年总生存率为100%。
70岁以上的患者能够耐受根治性放疗来治疗喉癌。尽管有轻度毒性反应,但所有患者均完成了治疗并取得了良好的肿瘤学结局。单独接受放疗而不适合同步化疗的III/IV期患者具有良好的无病生存率。不应基于年龄而不给老年患者进行根治性治疗。